Northern Trust Corp Oragenics Inc Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	BUY	$0.52 - $1.52 $63,435 - $185,427	121,992 Added 205.4%	181,383 $165,000
Q4 2020 Feb 11, 2021	BUY	$0.39 - $0.6 $6,815 - $10,485	17,476 Added 41.69%	59,391 $27,000
Q2 2020 Aug 14, 2020	SELL	$0.39 - $0.83 $1,070 - $2,277	-2,744 Reduced 6.14%	41,915 $29,000
Q3 2019 Nov 13, 2019	BUY	$0.36 - $0.64 $11,303 - $20,094	31,398 Added 236.77%	44,659 $24,000
Q1 2019 May 13, 2019	BUY	$0.57 - $1.05 $7,558 - $13,924	13,261 New	13,261 $8,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.